(Q39567732)

13 September 2017

1 reference

title

Induction chemotherapy for advanced head and neck cancers: a literature review (English)

1 reference

13 September 2017

1 reference

Chang TM

1

1 reference

13 September 2017

publication date

1 January 1988

1 reference

13 September 2017

1 reference

13 September 2017

volume

10

1 reference

13 September 2017

issue

3

1 reference

13 September 2017

page(s)

150-159

1 reference

Drugs five years later. Cisplatin

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

Cis-diamminedichloroplatinum (II). A new anticancer drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

Carcinoma of the tonsillar fossa: a nonrandomized comparison of preoperative radiation and surgery or irradiation alone: long-term results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

Combination of radiotherapy and surgery in the treatment of head and neck cancers

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

The value of combining radiotherapy with surgery in the treatment of hypopharyngeal and laryngeal cancers

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

Chemotherapy of cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

Integration of chemotherapy into a combined modality treatment plan for head and neck cancer: A review

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

Changing role of chemotherapy in treatment of head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

An overview of preoperative chemotherapy: where do we go from here?

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

What does "response" in cancer chemotherapy really mean?

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

Factors that affect response to chemotherapy and survival of patients with advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

INHIBITION OF CELL DIVISION IN ESCHERICHIA COLI BY ELECTROLYSIS PRODUCTS FROM A PLATINUM ELECTRODE

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

Cross-linking of Complementary Strands of DNA in Mammalian Cells by Antitumour Platinum Compounds

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

https://api.crossref.org/works/10.1002%2FHED.2890100303

1 reference

7 January 2021

High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

24-hour infusion of cis-platinum in head and neck cancers

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

https://api.crossref.org/works/10.1002%2FHED.2890100303

1 reference

7 January 2021

Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

Fluorouracil cardiotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

High dose methotrexate as a preoperative adjuvant in the treatment of epidermoid carcinoma of the head and neck. A feasibility study and clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

Improved survival for patients with advanced carcinoma of the head and neck treated with methotrexate-leucovorin prior to definitive radiotherapy or surgery

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

A randomized trial of adjuvant chemotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

Increased therapeutic index using moderate dose methotrexate and leucovorin twice weekly vs. weekly high dose methotrexate-leucovorin in patients with advanced squamous carcinoma of the head and neck: a safe new effective regimen

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

Induction bleomycin infusion in head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

Preoperative adjuvant chemotherapy in relatively advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

Cis-platinum induction chemotherapy in the multi-modality initial treatment of advanced stage IV carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

Combination therapy of advanced head and neck cancer: induction of remissions with diamminedichloroplatinum (II), bleomycin and radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

Induction chemotherapy in advanced squamous head and neck carcinoma with high-dose cis-platinum and bleomycin infusion

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

The adjuvant treatment of inoperable stage III and IV epidermoid carcinoma of the head and neck with platinum and bleomycin infusions prior to definitive radiotherapy: an RTOG pilot study

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

Preoperative Cisplatin and Bleomycin Therapy in Head and Neck Squamous Carcinoma: Prognostic Factors for Tumor Response

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

Preirradiation Chemotherapy for Advanced Head and Neck Carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

Adjuvant chemotherapy in advanced head and neck cancer. An update

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

Chemotherapy prior to local therapy in advanced squamous cell carcinoma of the head and neck: Preliminary assessment of an intensive drug regimen

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

Failure of effective initial chemotherapy to modify the course of stage IV (MO) squamous cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

Preoperative combination chemotherapy for advanced stage head and neck cancer. Promising early results

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

Superior clinical response and survival rates with initial bolus of cisplatin and 120 hour infusion of 5-fluorouracil before definitive therapy for locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

Adjuvant chemotherapy with cis-diamminodichloroplatinum II and 120-hour infusion 5-fluorouracil in Stage III and IV squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

Treatment of squamous-cell carcinoma of the head and neck with cisplatin and 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

Randomized study of adjuvant chemotherapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

Preoperative reductive chemotherapy for locally advanced carcinoma of the oral cavity, oropharynx, and hypopharynx

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

Histopathologic findings after cis-platinum bleomycin therapy in advanced previously untreated head and neck carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

Experience of the curie institute in treatment of cancer of the mobile tongue. I. Treatment policies and result

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

Carcinoma of the floor of the mouth

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

Carcinoma of the oral tongue and floor of mouth: fifteen years' experience with linear acceleration therapy

1 reference

https://api.crossref.org/works/10.1002%2FHED.2890100303

7 January 2021

Identifiers

DOI

10.1002/HED.2890100303

1 reference

release_ltin7vrb5ja5hjdnvz6blbwi5e

13 September 2017

Fatcat ID

0 references

1 reference